99 related articles for article (PubMed ID: 1598135)
1. [Outcome of patients with primary malignant lymphoma of the brain; relationship to the nucleolar organizer region].
Nakasu S; Nakazawa T; Saito A; Matsuda M; Handa J
No Shinkei Geka; 1992 May; 20(5):593-8. PubMed ID: 1598135
[TBL] [Abstract][Full Text] [Related]
2. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
3. Correlation between argyrophilic nucleolar organizer region staining and brain tumor classification and grading.
Quintana LG; da Silva FP; Pieczarka JC; Nagamachi CY; Anselmo NP; de Oliveira EH
Cancer Invest; 2010 Jun; 28(5):459-64. PubMed ID: 20014945
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
Babu M; Mathur M; Gupta SD; Chattopadhyay TK
Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
[TBL] [Abstract][Full Text] [Related]
5. Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas.
Hayashi H; Maeda T; Adachi E; Shimada M; Matsumata T; Takenaka K
Hepatogastroenterology; 1995; 42(5):440-4. PubMed ID: 8751192
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
Engel U; Plate K; Jänisch W; Mennel HD
Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma report of 32 cases and review of the literature.
Dubuisson A; Kaschten B; Lénelle J; Martin D; Robe P; Fassotte MF; Rutten I; Deprez M; Stevenaert A
Clin Neurol Neurosurg; 2004 Dec; 107(1):55-63. PubMed ID: 15567554
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar organizer regions in laryngeal cancer.
Klatka J; Skomra D
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():417-21. PubMed ID: 11977351
[TBL] [Abstract][Full Text] [Related]
9. [Clinical problems in the treatment of primary central nervous system malignant lymphoma].
Keyaki A; Nabeshima S; Hashimoto S; Waga S
No To Shinkei; 2000 Sep; 52(9):781-7. PubMed ID: 11064864
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions: a potential prognostic factor in adenocarcinoma of the endometrium.
Miller B; Morris M; Silva E
Gynecol Oncol; 1994 Aug; 54(2):137-41. PubMed ID: 8063236
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome?
Schaller C; Kelly PJ
Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and immunohistopathological study of primary malignant lymphoma of the brain].
Tamaki Y; Niibe H; Akimoto T; Kojima M; Honma M
Gan No Rinsho; 1988 Apr; 34(5):659-64. PubMed ID: 3260292
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma.
Morita M; Kuwano H; Matsuda H; Moriguchi S; Sugimachi K
Cancer Res; 1991 Oct; 51(19):5339-41. PubMed ID: 1913655
[TBL] [Abstract][Full Text] [Related]
16. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological study of lymphomas in the central nervous system--with the reference to the recurrence and proliferative activity.
Tanaka Y; Uematsu Y; Itakura T; Komai N
Noshuyo Byori; 1994; 11(2):181-6. PubMed ID: 7894623
[TBL] [Abstract][Full Text] [Related]
18. Primary cerebral lymphoma. A histologic and immunohistochemical study of six cases.
Grant JW; Gallagher PJ; Jones DB
Arch Pathol Lab Med; 1986 Oct; 110(10):897-901. PubMed ID: 3533002
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar organizer regions in bone tumors.
Ohno T; Tanaka T; Takeuchi S; Matsunaga T; Mori H
Clin Orthop Relat Res; 1991 Nov; (272):287-91. PubMed ID: 1934746
[TBL] [Abstract][Full Text] [Related]
20. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
